You are here:
Questions and Answers about Osteonecrosis (Avascular Necrosis)
This booklet contains general information about ostenecrosis (avascular necrosis). It describes what osteonecrosis is, who is likely to develop it, and how it is diagnosed. It also explains the symptoms and treatments. At the end is a list of key words to help you understand the terms used in this booklet. If you have further questions after reading this booklet, you may wish to discuss them with your doctor.
What Is Osteonecrosis?
Osteonecrosis is a disease resulting from the temporary or permanent loss of blood supply to the bones. Without blood, the bone tissue dies, and ultimately the bone may collapse. If the process involves the bones near a joint, it often leads to collapse of the joint surface. Osteonecrosis is also known as avascular necrosis, aseptic necrosis, and ischemic necrosis.
Although it can happen in any bone, osteonecrosis most commonly affects the ends (epiphysis) of the femur, the bone extending from the knee joint to the hip joint. Other common sites include the upper arm bone, knees, shoulders, and ankles. The disease may affect just one bone, more than one bone at the same time, or more than one bone at different times. Osteonecrosis of the jaw (ONJ) is a rare condition that has been linked to the use of biphosphonate medications. ONJ has different causes and treatments than osteonecrosis found in other parts of the skeleton. For more information on ONJ, contact the National Institute of Dental and Craniofacial Research.
The amount of disability that results from osteonecrosis depends on what part of the bone is affected, how large an area is involved, and how effectively the bone rebuilds itself. Normally, bone continuously breaks down and rebuilds—old bone is replaced with new bone. This process, which takes place after an injury as well as during normal growth, keeps the skeleton strong and helps it to maintain a balance of minerals. In the course of osteonecrosis, however, the healing process is usually ineffective and the bone tissues break down faster than the body can repair them. If left untreated, the disease progresses, the bone collapses, and the joint surface breaks down, leading to pain and arthritis.
Osteonecrosis is caused by impaired blood supply to the bone, but it is not always clear what causes that impairment. Osteonecrosis often occurs in people with certain medical conditions or risk factors (such as high-dose corticosteroid use or excessive alcohol intake). However, it also affects people with no health problems and for no known reason. Following are some potential causes of osteonecrosis and other health conditions associated with its development.
Aside from injury, one of the most common causes of osteonecrosis is the use of corticosteroid medications such as prednisone. Corticosteroids are commonly used to treat inflammatory diseases such as systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, severe asthma, and vasculitis. Studies suggest that long-term use of oral or intravenous corticosteroids is associated with nontraumatic osteonecrosis. Patients should discuss concerns about steroid use with their doctor.
Doctors are not sure exactly why the use of corticosteroids sometimes leads to osteonecrosis. They speculate that the drugs may interfere with the body’s ability to break down fatty substances called lipids. These substances then build up in and clog the blood vessels, causing them to narrow and to reduce the amount of blood that gets to the bone. Some studies suggest that corticosteroid-related osteonecrosis is more severe and more likely to affect both hips (when occurring in the hip) than osteonecrosis resulting from other causes.
Excessive alcohol use is another common cause of osteonecrosis. People who drink alcohol in excess can develop fatty substances that may block blood vessels, causing a decreased blood supply to the bones.
When a fracture, a dislocation, or some other joint injury occurs, the blood vessels may be damaged. This can interfere with the blood circulation to the bone and lead to trauma-related osteonecrosis. In fact, studies suggest that hip dislocation and hip fractures are major risk factors for osteonecrosis.
Increased pressure within the bone may be another cause of osteonecrosis. When there is too much pressure within the bone, the blood vessels narrow, making it hard for them to deliver enough blood to the bone cells. The cause of increased pressure is not fully understood.
Other Risk Factors
Other risk factors for osteonecrosis include radiation therapy, chemotherapy, and organ transplantation (particularly kidney transplantation). Osteonecrosis is also associated with a number of medical conditions, including cancer, systemic lupus erythematosus (SLE), blood disorders such as sickle cell disease, HIV infection, Gaucher’s disease, Caisson disease, gout, vasculitis, osteoarthritis, and osteoporosis.
Although osteonecrosis affects both men and women, it mainly affects men. However, in cases related to SLE, the disease mostly affects women. It can occur in people of any age, from children to the elderly. However, it is more common in people in their thirties, forties, and fifties.
In the early stages of osteonecrosis, people may not have any symptoms. As the disease progresses, however, most experience joint pain. At first, the pain occurs only when putting weight on the affected joint. Later, it occurs even when resting. Pain usually develops gradually, and may be mild or severe. If osteonecrosis progresses and the bone and surrounding joint surface collapse, pain may develop or increase dramatically. Pain may be severe enough to limit range of motion in the affected joint. In some cases, particularly those involving the hip, disabling osteoarthritis may develop. The period between the first symptoms and loss of joint function is different for each person, but it typically ranges from several months to more than a year.
After performing a complete physical examination and asking about the patient’s medical history, the doctor may use one or more bone imaging techniques to diagnose osteonecrosis. As with many other diseases, early diagnosis increases the chances of treatment success. The tests described below may be used to determine the amount of bone affected and how far the disease has progressed.
A radiograph, or x ray, may be the first test the doctor recommends. A simple way to produce pictures of bones, an x ray is often useful in diagnosing the cause of joint pain. For osteonecrosis, however, x rays are not sensitive enough to detect bone changes in the early stages of the disease. So if the x ray is normal, the doctor may order more tests. In later stages of osteonecrosis, x rays may show bone damage, and once the diagnosis is made, they are often used to monitor disease progression.
Magnetic Resonance Imaging (MRI)
Research studies have shown that magnetic resonance imaging, or MRI, is the most sensitive method for diagnosing osteonecrosis in the early stages. Unlike x rays, bone scans, and CT (computed/computerized tomography) scans (see below), MRI detects chemical changes in the bone marrow. MRI provides the doctor with a picture of the affected area and the bone-rebuilding process. In addition, MRI may show diseased areas that are not yet causing any symptoms. Some doctors caution against aggressive treatment of osteonecrosis that has been detected by MRI but is not causing symptoms. One study has shown evidence that for a select group of patients in the early stages of osteonecrosis, the disease may improve spontaneously.
Computed/Computerized Tomography (CT scan)
A CT scan is an imaging technique that provides the doctor with a three-dimensional picture of the bone. It also shows “slices” of the bone, making the picture much clearer than x rays and bone scans. Some doctors disagree about the usefulness of this test to diagnose osteonecrosis. Although a diagnosis usually can be made without a CT scan, the technique may be useful in determining the extent of bone damage. CT scans are less sensitive than MRIs.
A bone scan is used most commonly in patients who have normal x rays and no risk factors for osteonecrosis. In this test, a harmless radioactive material is injected through an intravenous line, and a picture of the bone is taken with a special camera. The picture shows how the injected material travels through blood vessels in bone. A single bone scan finds all areas in the body that are affected, thus reducing the need to expose the patient to more radiation.
A biopsy is a surgical procedure in which a tissue sample from the affected bone is removed and studied. Although a biopsy is a conclusive way to diagnose osteonecrosis, it is rarely used because it requires surgery.
Functional Evaluation of Bone
Tests to measure the pressure inside a bone may be used when the doctor strongly suspects that a patient has osteonecrosis, despite normal results of x rays, bone scans, and MRIs. These tests are very sensitive for detecting increased pressure within the bone, but they require surgery.
Appropriate treatment for osteonecrosis is necessary to keep joints from breaking down. Without treatment, most people with the disease will experience severe pain and limitation in movement. To determine the most appropriate treatment, the doctor considers the following:
- the age of the patient
- the stage of the disease (early or late)
- the location and whether bone is affected over a small or large area
- the underlying cause of osteonecrosis; with an ongoing cause such as corticosteroid or alcohol use, treatment may not work unless use of the substance is stopped.
The goal in treating osteonecrosis is to improve the patient’s use of the affected joint, stop further damage to the bone, and ensure bone and joint survival. To reach these goals, the doctor may use one or more of the following surgical or nonsurgical treatments.
Usually, doctors will begin with nonsurgical treatments, alone or in combination. Unfortunately, although these treatments may relieve pain or help in the short term, for most people they don’t bring lasting improvement.
- Medications. Nonsteroidal anti-inflammatory drugs (NSAIDs) are often prescribed to reduce pain.1 People with clotting disorders may be given blood thinners to reduce clots that block the blood supply to the bone. Cholesterol-lowering medications may be used to reduce fatty substances (lipids) that increase with corticosteroid treatment (a major risk factor for osteonecrosis).
- Reduced weight bearing. If osteonecrosis is diagnosed early, the doctor may begin treatment by having the patient remove weight from the affected joint. The doctor may recommend limiting activities or using crutches. In some cases, reduced weight bearing can slow the damage caused by osteonecrosis and permit natural healing. When combined with pain medication, reduced weight bearing can be an effective way to avoid or delay surgery for some patients.
- Range-of-motion exercises. An exercise program involving the affected joints may help keep them mobile and increase their range of motion.
- Electrical stimulation. This treatment has been used in several centers to induce bone growth, and in some studies has been helpful when used before femoral head collapse.
1Warning: NSAIDs can cause stomach irritation or, less often, they can affect kidney function. The longer a person uses NSAIDs, the more likely he or she is to have side effects, ranging from mild to serious. Many other drugs cannot be taken when a patient is being treated with NSAIDs because NSAIDs alter the way the body uses or eliminates these other drugs. Check with your health care provider or pharmacist before you take NSAIDs. Also, NSAIDs sometimes are associated with serious gastrointestinal problems, including ulcers, bleeding, and perforation of the stomach or intestine. People age 65 and older, as well as those with any history of ulcers or gastrointestinal bleeding, should use NSAIDs with caution.
A number of different surgical procedures are used to treat osteonecrosis. Most people with osteonecrosis will eventually need surgery.
- Core decompression. This surgical procedure removes the inner cylinder of bone, which reduces pressure within the bone, increases blood flow to the bone, and allows more blood vessels to form. Core decompression works best in people who are in the earliest stages of osteonecrosis, often before the collapse of the joint. This procedure sometimes reduces pain and slows the progression of bone and joint destruction.
- Osteotomy. This treatment involves reshaping the bone to reduce stress on the affected area. Recovery can be a lengthy process, requiring several months of very limited activities. This procedure is most effective for patients with early-stage osteonecrosis and those with a small area of affected bone.
- Bone graft. This is the transplantation of healthy bone from another part of the body. It is often used to support a joint after core decompression. In many cases, the surgeon will use what is called a vascular graft, which includes an artery and vein, to increase the blood supply to the affected area. Recovery from a bone graft can take several months.
- Arthroplasty/total joint replacement. Total joint replacement is the treatment of choice in late-stage osteonecrosis and when the joint is destroyed. In this surgery, the diseased joint is replaced with artificial parts. Total joint replacement, or sometimes femoral head resurfacing, is often recommended for people for whom other efforts to preserve the joint have failed. Various types of replacements are available, and people should discuss specific needs with their doctor.
For most people with osteonecrosis, treatment is an ongoing process. Depending upon the stage of the disease, doctors may first recommend the least complex or nonoperative treatment plans, such as medication or reduced weight bearing. If these modalities are unsuccessful, surgical treatments may be needed. It is important that patients carefully follow instructions about activity limitations and work closely with their doctors to ensure that appropriate treatments are used.
With proper treatment, most people with osteonecrosis can lead productive lives. But there is still a lot to learn about prevention, diagnosis, and treatment. Some goals of current research are to:
- Identify risk factors. For example, determine if genetic clotting disorders are risk factors for developing osteonecrosis in at-risk populations.
- Better understand the body’s reaction to steroids and why taking steroids increases a person’s risk of developing osteonecrosis.
- Identify and/or develop new ways to diagnose osteonecrosis in its earliest stages, when nonsurgical treatment is most likely to help.
- Develop new treatments and improve available treatments for osteonecrosis.
- Identify tissue engineering strategies that promote bone regeneration.
- Study key mechanical factors, such as the alignment of the hips, knees, and ankles, that influence treatment outcomes.
- Improve hip replacement techniques and materials so that younger patients will not need more than one hip replacement in their lifetime.
More information on research is available from the following websites:
- NIH Clinical Research Trials and You helps people learn more about clinical trials, why they matter, and how to participate. Visitors to the website will find information about the basics of participating in a clinical trial, first-hand stories from actual clinical trial volunteers, explanations from researchers, and links to how to search for a trial or enroll in a research-matching program.
- ClinicalTrials.gov offers up-to-date information for locating federally and privately supported clinical trials for a wide range of diseases and conditions.
- NIH RePORTER is an electronic tool that allows users to search a repository of both intramural and extramural NIH-funded research projects from the past 25 years and access publications (since 1985) and patents resulting from NIH funding.
- PubMed is a free service of the U.S. National Library of Medicine that lets you search millions of journal citations and abstracts in the fields of medicine, nursing, dentistry, veterinary medicine, the health care system, and preclinical sciences.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institutes of Health
NIH Osteoporosis and Related Bone Diseases ~ National Resource Center
National Institute of Dental and Craniofacial Research
American Academy of Orthopaedic Surgeons
National Osteonecrosis Foundation
The Hip Society
For additional contact information, visit the NIAMS website or call the NIAMS Information Clearinghouse.
Arthritis. Literally means joint inflammation. It is a general term for more than 100 of the rheumatic diseases. Arthritis causes joint swelling, pain, and stiffness.
Arthroplasty. Another name for total joint replacement. A procedure in which a damaged joint is surgically removed and replaced with an artificial prosthesis. It is the treatment of choice for osteonecrosis when the joint is destroyed.
Asceptic necrosis. See osteonecrosis.
Autoimmune disease. A disease that results when the immune system mistakenly attacks the body’s own tissues.
Avascular necrosis. See osteonecrosis.
Biopsy. A procedure in which tissue is removed from the body and studied under a microscope. A bone biopsy is a conclusive way to diagnose osteonecrosis.
Blood vessels. Arteries, veins, and capillaries that carry blood through the body.
Bone graft. The transplantation of healthy bone from one part of the body to replace injured or diseased bone in another part of the body.
Bone morphogenic protein. A protein extracted from the body and synthesized through genetic engineering. Research suggests it may be used to promote growth of bone damaged by osteonecrosis.
Bone scan. A type of test called technetium-99m bone scanning is used most commonly in patients who have normal x rays and no risk factors for osteonecrosis. In this test, a harmless radioactive material is injected through an intravenous line, and a picture of the bone is taken with a special camera. The picture shows how the injected material travels through blood vessels in bone. A single bone scan finds all areas in the body that are affected, thus reducing the need to expose the patient to more radiation.
Caisson disease. A syndrome that occurs when deep-sea divers, construction workers, or others working in a pressurized environment return to normal atmospheric pressure. Nitrogen in the bloodstream expands to form bubbles, causing pain and blocking circulation in the small blood vessels. The condition can potentially lead to osteonecrosis.
Cancer. A term for diseases in which abnormal cells divide without control. Cancer cells can invade nearby tissues and can spread through the bloodstream and lymphatic system to other parts of the body.
Cholesterol. Fat-like material present in the blood and most tissues. High levels of cholesterol can be a risk factor in the development of osteonecrosis as well as cardiovascular disease.
Computed (or computerized) tomography (CT) scan. An imaging technique that provides the doctor with a three-dimensional picture of the bone. It also shows “slices” of the bone, making the picture much clearer than x rays and bone scans.
Core decompression. A surgical procedure in which the inner layer of the bone is removed to reduce pressure within the bone, thereby increasing blood flow to the bone. In people with early osteonecrosis, the procedure may reduce pain and slow the progression of bone and joint destruction.
Corticosteroids. Powerful anti-inflammatory hormones made naturally in the body or manmade for use as medicine. Using corticosteroid medications is a risk factor for developing osteonecrosis.
Electrical stimulation. A procedure in which electromagnetic fields are set up around the bones or electricity is applied directly to the bones to induce bone growth. In some centers it has been helpful in treating patients with osteonecrosis before the collapse of the femoral head.
Epiphysis. The end of a bone where it meets another bone or bones to form a joint.
Femoral head. The round bony protrusion at the end of the thigh bone that fits into the acetabulum (socket) of the pelvis to form the hip joint. The femoral head often collapses in advanced osteonecrosis.
Femur. The upper leg, or thigh, bone. The end of the femur, where it meets the pelvis, is the most common site of osteonecrosis.
Gaucher’s disease. A congenital disease in which there is accumulation of fatty compounds in the liver, spleen, lymph nodes, and nervous system. Having the disease has been associated with the development of osteonecrosis.
Gout. A type of arthritis caused by the reaction of the body to needle-like crystals of uric acid that accumulate in joint spaces. This reaction causes joint inflammation, swelling, and pain in the affected joint, most commonly the big toe.
HIV (human immunodeficiency virus). The virus that causes AIDS.
Immune system. A complex network of specialized cells and organs that work together to defend the body against attacks by “foreign” invaders such as bacteria and viruses. In some rheumatic conditions, it appears that the immune system does not function properly and may even work against the body.
Inflammation. A reaction of tissues to injury or disease, marked by four signs: swelling, redness, heat, and pain.
Ischemic necrosis. See osteonecrosis.
Lupus. Systemic lupus erythematosus (also known as lupus or SLE) is an autoimmune disease in which the immune system harms the body’s own healthy cells and tissues. This can result in inflammation of and damage to the joints, skin, kidneys, heart, lungs, blood vessels, and brain.
Magnetic resonance imaging (MRI). A procedure in which a strong magnet is used to pass a force through the body to create a clear, detailed image of a cross-section of the body. MRI detects chemical changes in the bone marrow and can show osteonecrosis in its earliest stages, often before it causes any symptoms.
Meniscus. A crescent-shaped wedge of cartilage in the knee joint. Tears of the meniscus have been associated with the development of both osteonecrosis and osteoarthritis in the knee.
Orthopaedist. A doctor who specializes in diseases of and traumatic injuries to the bones and musculoskeletal system. Also called orthopaedic surgeon.
Osteoarthritis. A disease in which the cartilage that cushions the ends of the bones breaks down, leading to joint pain and stiffness. The most common form of arthritis, osteoarthritis grows more common with age.
Osteonecrosis. A disease in which a temporary or permanent loss of the blood supply to the bones causes bone tissue to die and the bone to collapse. Also known as avascular necrosis, aseptic necrosis, and ischemic necrosis.
Osteonecrosis of the jaw (ONJ). A rare condition that has been linked to the use of biphosphonate medications. ONJ has different causes and treatments than osteonecrosis found in other parts of the skeleton.
Osteoporosis. A disease in which the bone loses density and becomes so porous that it can break as a result of even minor trauma.
Osteotomy. A surgical procedure that involves reshaping the bone to reduce stress on a diseased or damaged area of a joint. It is often used for patients with advanced osteonecrosis and those with a large area of affected bone.
Range-of-motion exercises. A program of exercises involving joints affected by arthritis. These exercises may help keep the joint mobile and increase range of motion.
Sickle cell disease. A hereditary blood disease characterized by the production of an abnormal type of hemoglobin in the red blood cells. Having the disease increases one’s risk of osteonecrosis.
Vasculitis. A disease in which there is inflammation of the blood vessels. Having vasculitis may increase one’s risk of osteonecrosis.
The NIAMS gratefully acknowledges the assistance of the following individuals in the preparation and review of the original version of this booklet: Thomas D. Brown, Ph.D., University of Iowa, Iowa City, IA; Harry E. Rubash, M.D., Asit Shah, M.D., and Jeffrey Geller, M.D., Massachusetts General Hospital, Boston, MA; and James Panagis, M.D., M.P.H., NIAMS/NIH.
The mission of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a part of the U.S. Department of Health and Human Services’ National Institutes of Health (NIH), is to support research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases; the training of basic and clinical scientists to carry out this research; and the dissemination of information on research progress in these diseases. The NIAMS Information Clearinghouse is a public service sponsored by the NIAMS that provides health information and information sources. Additional information can be found on the NIAMS website at www.niams.nih.gov.
For Your Information
This publication contains information about medications used to treat the health condition discussed here. When this publication was developed, we included the most up-to-date (accurate) information available. Occasionally, new information on medication is released.
For updates and for any questions about any medications you are taking, please contact
U.S. Food and Drug Administration
Toll Free: 888–INFO–FDA (888–463–6332)
For additional information on specific medications, visit Drugs@FDA at www.accessdata.fda.gov/scripts/cder/drugsatfda. Drugs@FDA is a searchable catalog of FDA-approved drug products.
For updates and questions about statistics, please contact
Centers for Disease Control and Prevention’s National Center for Health Statistics
This publication is not copyrighted. Readers are encouraged to duplicate and distribute as many copies as needed.
Additional copies of this publication are available from:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institutes of Health
NIH Publication No. 09–4857